These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

458 related items for PubMed ID: 15242735

  • 1. Tumor necrosis factor-alpha does not modulate ischemia/reperfusion injury in naïve myocardium but is essential for the development of late preconditioning.
    Dawn B, Guo Y, Rezazadeh A, Wang OL, Stein AB, Hunt G, Varma J, Xuan YT, Wu WJ, Tan W, Zhu X, Bolli R.
    J Mol Cell Cardiol; 2004 Jul; 37(1):51-61. PubMed ID: 15242735
    [Abstract] [Full Text] [Related]

  • 2. Adenosine prevents activation of transcription factor NF-kappa B and enhances activator protein-1 binding activity in ischemic rat heart.
    Li C, Ha T, Liu L, Browder W, Kao RL.
    Surgery; 2000 Feb; 127(2):161-9. PubMed ID: 10686981
    [Abstract] [Full Text] [Related]

  • 3. [Cardioprotection of recombinant human erythropoietin pretreatment on ischemia-reperfused hearts and mechanism thereof: experiment with rats].
    Liu XM, Jia Z, Zhou ZQ, Xu JG.
    Zhonghua Yi Xue Za Zhi; 2007 Sep 18; 87(35):2463-7. PubMed ID: 18067805
    [Abstract] [Full Text] [Related]

  • 4. Activation of NF kappa B and expression of ICAM-1 in ischemic-reperfused canine myocardium.
    Sun B, Fan H, Honda T, Fujimaki R, Lafond-Walker A, Masui Y, Lowenstein CJ, Becker LC.
    J Mol Cell Cardiol; 2001 Jan 18; 33(1):109-19. PubMed ID: 11133227
    [Abstract] [Full Text] [Related]

  • 5. Low-dose TNF-alpha protects against hepatic ischemia-reperfusion injury in mice: implications for preconditioning.
    Teoh N, Leclercq I, Pena AD, Farrell G.
    Hepatology; 2003 Jan 18; 37(1):118-28. PubMed ID: 12500196
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of myocardial apoptosis by postconditioning is associated with attenuation of oxidative stress-mediated nuclear factor-kappa B translocation and TNF alpha release.
    Kin H, Wang NP, Mykytenko J, Reeves J, Deneve J, Jiang R, Zatta AJ, Guyton RA, Vinten-Johansen J, Zhao ZQ.
    Shock; 2008 Jun 18; 29(6):761-8. PubMed ID: 18496137
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. TLR ligand decreases mesenteric ischemia and reperfusion injury-induced gut damage through TNF-alpha signaling.
    Chen LW, Chang WJ, Chen PH, Liu WC, Hsu CM.
    Shock; 2008 Nov 18; 30(5):563-70. PubMed ID: 18317407
    [Abstract] [Full Text] [Related]

  • 9. Dual activation of STAT-3 and Akt is required during the trigger phase of ischaemic preconditioning.
    Suleman N, Somers S, Smith R, Opie LH, Lecour SC.
    Cardiovasc Res; 2008 Jul 01; 79(1):127-33. PubMed ID: 18339648
    [Abstract] [Full Text] [Related]

  • 10. Ischemic preconditioning improves rat kidney allograft function after ischemia/reperfusion injury: the role of tumor necrosis factor-alpha.
    Jia RP, Xie JJ, Luo FY, Zhu JG.
    Transplant Proc; 2008 Dec 01; 40(10):3316-20. PubMed ID: 19100380
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of ischaemic preconditioning in the eNOS overexpressed working mouse heart model.
    du Toit EF, Genade S, Carlini S, Moolman JA, Brunner F, Lochner A.
    Eur J Pharmacol; 2007 Feb 05; 556(1-3):115-20. PubMed ID: 17157294
    [Abstract] [Full Text] [Related]

  • 12. Remote preconditioning by infrarenal aortic occlusion is operative via delta1-opioid receptors and free radicals in vivo in the rat heart.
    Weinbrenner C, Schulze F, Sárváry L, Strasser RH.
    Cardiovasc Res; 2004 Feb 15; 61(3):591-9. PubMed ID: 14962489
    [Abstract] [Full Text] [Related]

  • 13. [Effect of propofol on the activation of nuclear factor-kappa B and expression of inflammatory cytokines in cerebral cortex during transient focal cerebral ischemia-reperfusion: experiment with rats].
    Feng CS, Ma HC, Yue Y, Zhang YQ, Qu XD.
    Zhonghua Yi Xue Za Zhi; 2004 Dec 17; 84(24):2110-4. PubMed ID: 15730629
    [Abstract] [Full Text] [Related]

  • 14. Myocardial protection by remote preconditioning: the role of nuclear factor kappa-B p105 and inducible nitric oxide synthase.
    Li G, Labruto F, Sirsjö A, Chen F, Vaage J, Valen G.
    Eur J Cardiothorac Surg; 2004 Nov 17; 26(5):968-73. PubMed ID: 15519191
    [Abstract] [Full Text] [Related]

  • 15. Pharmacological preconditioning with tumor necrosis factor-alpha activates signal transducer and activator of transcription-3 at reperfusion without involving classic prosurvival kinases (Akt and extracellular signal-regulated kinase).
    Lecour S, Suleman N, Deuchar GA, Somers S, Lacerda L, Huisamen B, Opie LH.
    Circulation; 2005 Dec 20; 112(25):3911-8. PubMed ID: 16344382
    [Abstract] [Full Text] [Related]

  • 16. Dynamism of NF-kappaB and AP-1 activation in the signal transduction of ischaemic myocardial preconditioning.
    Jancso G, Lantos J, Borsiczky B, Szanto Z, Roth E.
    Eur Surg Res; 2004 Dec 20; 36(3):129-35. PubMed ID: 15178900
    [Abstract] [Full Text] [Related]

  • 17. IL-6 plays an obligatory role in late preconditioning via JAK-STAT signaling and upregulation of iNOS and COX-2.
    Dawn B, Xuan YT, Guo Y, Rezazadeh A, Stein AB, Hunt G, Wu WJ, Tan W, Bolli R.
    Cardiovasc Res; 2004 Oct 01; 64(1):61-71. PubMed ID: 15364614
    [Abstract] [Full Text] [Related]

  • 18. Absence of inducible nitric oxide synthase modulates early reperfusion-induced NF-kappaB and AP-1 activation and enhances myocardial damage.
    Zingarelli B, Hake PW, Yang Z, O'Connor M, Denenberg A, Wong HR.
    FASEB J; 2002 Mar 01; 16(3):327-42. PubMed ID: 11874982
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of TNF-alpha reduces myocardial injury and proinflammatory pathways following ischemia-reperfusion in the dog.
    Gu Q, Yang XP, Bonde P, DiPaula A, Fox-Talbot K, Becker LC.
    J Cardiovasc Pharmacol; 2006 Dec 01; 48(6):320-8. PubMed ID: 17204912
    [Abstract] [Full Text] [Related]

  • 20. Ischemic preconditioning upregulates inducible nitric oxide synthase in cardiac myocyte.
    Wang Y, Guo Y, Zhang SX, Wu WJ, Wang J, Bao W, Bolli R.
    J Mol Cell Cardiol; 2002 Jan 01; 34(1):5-15. PubMed ID: 11812160
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.